Complete Genomics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 85   

Articles published

GNOM 3.14
price chart
Complete Genomics: A Leader In DNA Sequencing
Complete Genomics delivered data for approximately 2,200 genomes, including approximately 100 non-revenue generating genomes, for its clinical validation study with the Mayo Clinic and its cancer grant programs.
Related articles »  
BGI-Shenzhen Agrees to Buy Complete Genomics
BGI-Shenzhen, a Chinese operator of genome-sequencing centers, agreed to acquire Complete Genomics Inc. (GNOM) for about $117.6 million to expand in the U.S.
Complete Genomics: Say No To Sale  Seeking Alpha
Chinese DNA company to buy Complete Genomics  The Deal Pipeline
Related articles »  
Complete Genomics chief returns fire on CFIUS warning
by William McConnell In Washington | Published December 14, 2012 at 8:25 AM Complete Genomics Inc. chairman Clifford A. Reid is firing back at thwarted suitor Illumina Inc., a rival in the genome sequencing business whose executives have predicted ...
Related articles »  
Illumina, Complete Genomics Settle Patent Disputes
Law360, Los Angeles (July 18, 2013, 8:04 PM ET) -- Complete Genomics Inc. and Illumina Inc. have agreed to settle all claims in two separate patent infringement cases brought by Illumina over four of its patents, without payment being made by either ...
Related articles »  
Complete Genomics: Say No To The Sale - Part 2
It's tragic that Complete Genomics (NASDAQ:GNOM) is being sold for a price that you would put on to expired aspirin. Among all the chatter that has surrounded the company subsequent to the buyout announcement, no one has said that $3.15 is a fair price.
Related articles »  
Complete Genomics Says Its Probes Differ From Illumina's
Law360, San Francisco (February 20, 2013, 4:06 PM ET) -- Complete Genomics Inc. urged a California federal judge on Wednesday to rule that its genome-testing kits do not violate Illumina Inc.'s patents, arguing that it has produced enough evidence that ...
Complete Genomics, A Complete Future?
With the cost of whole-genome sequencing (WGS) rapidly declining from millions to mere thousands today, medicine is in the midst of a major revolution.
Related articles »  
BGI-Shenzhen Acquires US-Based Complete Genomics For $117M
19, 2013) - BGI, a genomics company based in Shenzhen, China, has successfully acquired U.S.-based whole human genomic sequencing provider, Complete Genomics, Inc., through its wholly-owned subsidiary, Beta Acquisition Corporation.
Related articles »  
Complete Genomics rejects Illumina bid over Chinese acquirer
Complete Genomics Inc. rejected a $123.5 million acquisition bid from Illumina Inc., a victory for potential buyer BGI-Shenzhen of China.
Related articles »  
Complete Genomics' IPO Meets With Lukewarm Reception
DNA sequencing firm Complete Genomics (NASDAQ:GNOM) went public after scaling back its deal price more than 30 percent to get it done.